Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Phase 1 study to provide quantitative characterization of the renal elimination of ethacrynic
acid and metabolites in patients with non-muscle invasive bladder cancer (NMIBC) at the time
of transurethral resection of bladder tumor
Phase:
Phase 1
Details
Lead Sponsor:
Eugene Lee, MD University of Kansas Medical Center